Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy

BACKGROUND: Galectin‐3 (GAL3), a protein encoded by the LGALS3 gene, plays diverse roles in cancer initiation, progression, and drug resistance. Accordingly, high GAL3 expression in tumor cells is associated with poor prognosis in non‐small cell lung cancer (NSCLC). However, the prognostic impact of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Thorac Cancer
Hlavní autoři: Kusuhara, Seiichiro, Igawa, Satoshi, Ichinoe, Masaaki, Nagashio, Ryo, Kuchitsu, Yuki, Hiyoshi, Yasuhiro, Shiomi, Kazu, Murakumo, Yoshiki, Saegusa, Makoto, Satoh, Yukitoshi, Sato, Yuichi, Naoki, Katsuhiko
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons Australia, Ltd 2021
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107024/
https://ncbi.nlm.nih.gov/pubmed/33793071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13945
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky